Viewing nowCombinationLostel Tablet 80/5 mg
Telmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 201506817 · Approved 2015.09.25 · Insurance code 651204390
Treatment of hypertension, improvement of dyslipidemia, and suppression of the progression of atherosclerosis and the risk of cardiovascular disease
This medication is used for patients who require the concurrent administration of both telmisartan and rosuvastatin. First, telmisartan is used to control blood pressure in patients with essential hypertension and help reduce the risk of myocardial infarction, stroke, and mortality due to cardiovascular disease in patients aged 55 years or older who are at high risk for major cardiovascular disease. It is also used as an alternative treatment for patients who cannot take ACE inhibitors. Meanwhile, rosuvastatin calcium is used in conjunction with dietary therapy for patients with hypercholesterolemia and various forms of dyslipidemia to lower serum cholesterol and LDL-cholesterol levels and delay the progression of atherosclerosis. Additionally, it aids in homozygous familial hypercholesterolemia and abnormal beta-lipoproteinemia, and is particularly effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization in patients who are at high risk for cardiovascular disease. Therefore, this medication is used to comprehensively improve cardiovascular health in patients with hypertension and dyslipidemia.
In a drug interaction study of telmisartan 80mg and rosuvastatin 20mg, the active ingredients of this medicine, the Cmax and AUC of telmisartan in the presence of rosuvastatin were approximately 0.87-fold and 1.00-fold, respectively, while the Cmax and AUC of rosuvastatin in the presence of telmisartan increased approximately 1.71-fold and 1.16-fold, respectively. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor patients closely. This medicine is for use in adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This medicine produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after initiation of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be necessary. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborn during pregnancy, so if pregnancy is confirmed, consumption must be stopped immediately. Patients with allergies to this medication or its components, pregnant or breastfeeding women, or fertile women who are not using adequate contraception should not take this medication. Patients with severe liver dysfunction or problems with bile secretion should not take this medication. Patients at high risk of myopathy or rhabdomyolysis, those with severe renal impairment, and those using certain immunosuppressants or antidiabetic agents should also refrain from taking this medication. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver dysfunction should take this medication cautiously, and liver function tests and muscle-related symptoms should be checked regularly. Special caution is needed when administering this medication to patients with cardiovascular disease, gastrointestinal disease, or renal artery hypertension. If symptoms such as muscle pain, weakness, or cramps occur, consult a physician immediately and undergo necessary tests. This medication may interact with other antihypertensives, diuretics, potassium-sparing agents, some antibiotics, antifungals, immunosuppressants, etc., so inform your doctor or pharmacist about any other medications you are taking. During treatment, it is important to regularly monitor liver function tests, serum creatinine, potassium levels, and muscle enzyme levels. In case of overdose, hypotension, dizziness, acute renal failure may occur, so visit a medical institution immediately for appropriate treatment. During this treatment, caution should be taken when driving or operating machinery, as drowsiness or dizziness may occur. Keep this medication out of the reach of children and do not transfer it to other containers for safety.
Headache, positional dizziness, sleep paralysis, increased blood pressure, decreased blood pressure, hypotension, ALT elevation, dysuria, rhinitis, discomfort in the oropharynx, pulmonary diseases, unspecified gastrointestinal disorders, benign gastrointestinal neoplasms, hemorrhoids, musculoskeletal pain, osteoporosis, sensory reduction, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory tract infections, pharyngitis, sinusitis, urinary tract infections, cystitis, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reactions, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver dysfunction, hepatic impairment, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, hypoglycemia, angioedema, symptoms of hypotension due to blood volume depletion and sodium depletion, intravascular volume depletion, increased serum potassium and creatinine levels, syncope due to blood pressure drop, loss of consciousness, liver dysfunction, jaundice, symptoms resembling anaphylaxis, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, insufficient efficacy, facial spasms, sensory abnormalities, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, arrhythmia, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, polyneuropathy, memory loss, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, severe muscular weakness, ocular muscle weakness, constipation, nausea, pancreatitis, itching, rash, urticaria, myopathy, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent air or moisture from entering, at a temperature between 1°C and 30°C (room temperature) for safety. By storing it this way, the effectiveness of the medication can be maintained for a longer period.
Bright pink oval film-coated tablet
30 tablets (10 tablets/Alu-Alu) x 3
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.